Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantern Pharma Inc (NQ: LTRN )

3.860 +0.020 (+0.52%)
Streaming Delayed Price Updated: 3:37 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantern Pharma Inc

< Previous 1 2 3 Next >
3 AI Stocks That Still Trade Under $10 Per Share
With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023
Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices. 
Via InvestorPlace
The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023
Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True
These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection. 
Via InvestorPlace
3 AI Stocks You’ll Regret Not Buying Soon
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in. 
Via InvestorPlace
Lantern Pharma's Earnings: A Preview
Via Benzinga
Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate
Via Benzinga
Recap: Lantern Pharma Q2 Earnings
  Lantern Pharma (NASDAQ:LTRN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
7 AI Stocks to Buy Under $5 in August 2023
These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond. 
Via InvestorPlace
3 AI Stocks to Buy Under $10 in August 2023
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10. 
Via InvestorPlace
7 AI Penny Stocks that Could Hit $5 Soon
Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
3 Penny Stocks to Buy as the AI Sector Transforms Every Industry in 2023
These AI penny stocks could potentially offer potent long-term value at tremendously attractive prices at this time 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
7 AI Penny Stocks That Could Skyrocket in 2023
AI penny stocks represent great potential and high returns, given the fact this technology is only beginning to pervade society. 
Via InvestorPlace
Earnings Preview: Lantern Pharma
Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Lantern Pharma... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
Treating Pediatric Cancer? How Lantern Pharma Hopes To Improve The Lives Of Pediatric Cancer Patients During Childhood Cancer Awareness Month
Every September organizations have worked to raise awareness for childhood cancer by participating in childhood cancer awareness month.  
Via Benzinga
Lantern Pharma's New Phase 2 Clinical Trial –Harmonic™ — Approved for Launch by the FDA
When most people think of lung cancer, they often picture a smoker. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study
The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with... 
Via Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Lantern Pharma Q1 Earnings
Lantern Pharma (NASDAQ:LTRN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lantern Pharma missed estimated... 
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Lantern Pharma Earnings Preview
Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lantern... 
Via Benzinga
Lantern Pharma: Q4 Earnings Insights
Lantern Pharma (NASDAQ:LTRN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.